Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Clinical trial NCT00060684 · COMPLETED

Trial details

NCT number: NCT00060684
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Low-Grade Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular

Start date: 2001-12-01
Primary completion: 2005-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.